title: [Cytolytic hepatic damage caused by ciprofibrate].
authors.forename: M C
authors.initials: MC
authors.lastname: Perault
authors.forename: J L
authors.initials: JL
authors.lastname: Fievre
authors.forename: C
authors.initials: C
authors.lastname: Dejean
authors.forename: A
authors.initials: A
authors.lastname: Martin
authors.forename: B
authors.initials: B
authors.lastname: Vandel
mesh_terms: D000368:Aged; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000209:etiology; D002995:Clofibric Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D058607:Fibric Acids; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D008107:Liver Diseases / Q000201:enzymology
chemical_list: D058607:Fibric Acids; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; C019304:ciprofibrate
vernacular_title: Atteinte hépatique cytolytique associée à la prise de ciprofibrate.